Michelle Tarver, who will officially replace longtime CDRH leader Jeff Shuren, emphasized the agency’s focus on patients in comments last week.

Advamed’s largest — featured an appearance by the device center’s new acting director and sessions on AI, clinical trial diversity and the FDA’s contentious LDT rule.

Johnson & Johnson, Abbott and Intuitive Surgical made a mixed start to earnings season last week. The second wave of the medtech industry’s latest earnings season arrives this week, with Boston ...

The AI Innovation Lab is designed to to accelerate early concept artificial intelligence projects including tools to predict the recurrence of cancer and automate image interpretation.

Findings from a new survey of executives in MedTech companies reveal that the majority of their revenues come through contracts with healthcare facilities, integrated delivery networks (IDNs) and ...

DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 56,000 newsletter subscribers for 21 days.

Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.

BTIG analysts wrote that installations of Intuitive’s new robotic surgery system are “well ahead of lofty” expectations.

Former CDRH leader Jeff Shuren told an audience at The Medtech Conference that Michelle Tarver “will make an excellent center director, and quite frankly, the best is yet to come.” ...